ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
1-Year Return 11.37%
This Quarter Return
+10.92%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$6.36B
AUM Growth
+$617M
Cap. Flow
+$259M
Cap. Flow %
4.07%
Top 10 Hldgs %
71.18%
Holding
48
New
4
Increased
12
Reduced
9
Closed
5

Top Buys

1
XLRN
Acceleron Pharma Inc.
XLRN
$172M
2
APLS icon
Apellis Pharmaceuticals
APLS
$132M
3
FOLD icon
Amicus Therapeutics
FOLD
$49.9M
4
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$44.9M
5
PMVP icon
PMV Pharmaceuticals
PMVP
$32.8M

Top Sells

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
$108M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
$38.7M
3
RLMD icon
Relmada Therapeutics
RLMD
$29.9M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$28.3M
5
SNDX icon
Syndax Pharmaceuticals
SNDX
$27.8M

Sector Composition

1 Healthcare 97.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNS
26
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$36.8M 0.58%
3,235,000
– –
ACAD icon
27
Acadia Pharmaceuticals
ACAD
$4.26B
$36.5M 0.57%
2,200,000
-241,658
-10% -$4.01M
DCPH
28
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$36.3M 0.57%
1,068,000
– –
AMRN
29
Amarin Corp
AMRN
$317M
$30.6M 0.48%
300,000
– –
PRAX icon
30
Praxis Precision Medicines
PRAX
$986M
$29.6M 0.46%
106,667
– –
SNDX icon
31
Syndax Pharmaceuticals
SNDX
$1.47B
$29.5M 0.46%
1,545,000
-1,455,000
-49% -$27.8M
RNA icon
32
Avidity Biosciences
RNA
$6.48B
$28.3M 0.44%
1,150,000
+605,000
+111% +$14.9M
KYMR icon
33
Kymera Therapeutics
KYMR
$3.11B
$26.8M 0.42%
+455,750
New +$26.8M
DICE
34
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$26.2M 0.41%
+800,000
New +$26.2M
BIIB icon
35
Biogen
BIIB
$20.6B
$23.8M 0.37%
+84,000
New +$23.8M
AVDL
36
Avadel Pharmaceuticals
AVDL
$1.53B
$22.3M 0.35%
2,275,000
-2,090,000
-48% -$20.5M
NUVL icon
37
Nuvalent
NUVL
$5.83B
$22.3M 0.35%
+1,257,671
New +$22.3M
DSGN icon
38
Design Therapeutics
DSGN
$367M
$21.6M 0.34%
1,468,318
– –
TNGX icon
39
Tango Therapeutics
TNGX
$772M
$20M 0.31%
1,550,000
+750,000
+94% +$9.7M
FENC icon
40
Fennec Pharmaceuticals
FENC
$250M
$15.7M 0.25%
1,670,000
– –
ADVM icon
41
Adverum Biotechnologies
ADVM
$73.9M
$15.1M 0.24%
695,000
– –
MRUS icon
42
Merus
MRUS
$5.1B
$9.9M 0.16%
450,000
-210,000
-32% -$4.62M
GNCA
43
DELISTED
Genocea Biosciences, Inc.
GNCA
$9.76M 0.15%
5,084,184
– –
ADAP
44
Adaptimmune Therapeutics
ADAP
$10.9M
– –
-2,024,400
Closed -$8.62M
CNTA
45
Centessa Pharmaceuticals
CNTA
$2.11B
– –
-500,000
Closed -$11.1M
OLMA icon
46
Olema Pharmaceuticals
OLMA
$570M
– –
-876,986
Closed -$24.5M
RLMD icon
47
Relmada Therapeutics
RLMD
$54.8M
– –
-935,000
Closed -$29.9M
CNST
48
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-3,210,000
Closed -$108M
1
2